Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation

Liver Transplantation

Volumn 14, Issue 9, 2008, Pages 1357-1365

  Rybak, Debbie ^a   Fallon, Michael B ^c   Krowka, Michael J ^d   Brown Jr , Robert S ^a   Reinen, Jenna ^a   Stadheim, Linda ^d   Faulk, Dorothy ^c   Nielsen, Carrie ^e   Al Naamani, Nadine ^a   Roberts, Karl ^f   Zacks, Steven ^e   Perry, Ted ^g   Trotter, James ^g   Kawut, Steven M ^a,b   Okun, Jeffrey ^h   Rabinowitz, Daniel ^h   Horn, Evelyn M ^h   Rosenthal, Lori ^h   Olsen, Sonja ^h   Shah, Vijay ^d   Wiesner, Russell ^d   Bynon, J Stevenson ⁱ   Eckhoff, Devin ⁱ   Singh, Harpreet ⁱ   Tanikella, Rajasekhar ⁱ   Benza, Raymond L ⁱ   Wille, Keith ⁱ   Forman, Lisa ^j   Badesch, David ^j   Shrestha, Roshan ^k   Taichman, Darren B ^l   Ahya, Vivek ^l   Palevsky, Harold ^l   Reddy, Rajender ^l   Kaplowitz, Neil ^m   Knowles, James ^m   more..

^a Columbia University ^*  (United States)

^b Department of Medicine   (United States)

^c University of Alabama at Birmingham   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f TUFTS MEDICAL CENTER   (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^h Mayo Clinic ^*  (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j UNIVERSITY OF COLORADO   (United States)

^k UNIVERSITY OF NORTH CAROLINA   (United States)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

^m UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HIGH RISK PATIENT; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SHORT FORM 36; SMOKING; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; SMOKING; TREATMENT OUTCOME;

EID: 51349148985     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21545     Document Type: Article

References (26)

1. Angueira CE, Kadakia SC. Effects of large-volume paracentesis on pulmonary function in patients with tense cirrhotic ascites. Hepatology 1994;20:825-828.
2. Hourani JM, Bellamy PE, Tashkin DP, Batra P, Simmons MS. Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. Am J Med 1991;90:693-700.
3. Krowka MJ, Dickson ER, Wiesner RH, Krom RA, Atkinson B, Cortese DA. A prospective study of pulmonary function and gas exchange following liver transplantation. Chest 1992:102:1161-1166.
4. Mohamed R, Freeman JW, Guest PJ, Davies MK, Neuberger JM. Pulmonary gas exchange abnormalities in liver transplant candidates. Liver TranspI 2002;8:802-808.
5. Yao EH, Kong BC, Hsue GL, Zhou AC, Wang H. Pulmonary function changes in cirrhosis of the liver. Am J Gastroenterol 1987;82:352-354.
6. Zein CO, Beatty K, Post AB, Logan L, Debanne S, McCullough AJ. Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment. Hepatology 2006;44:1564-1571.
7. Trichopoulos D, MacMahon B, Sparros L, Merikas G. Smoking and hepatitis B-negative primary hepatocellular carcinoma. J Natl Cancer Inst 1980;65:111-114.
8. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 2001;34: 121-125.
9. Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, et al. Clinical risk factors for portopulmonary hypertension. Hepatology 2008. doi://10.1002/hep.22275. Available at: http://www3.interscience.wiley.com.
10. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470.
11. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981;123:185-189.
12. Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 1982;18:419-425.
13. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
14. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004;24:861-880.
15. Gralnek IM, Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Artinian L, et al. Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease - the LDQOL 1.0. Am J Gastroenterol 2000;95:3552-3565.
16. Ware JE Jr, Sherbourne CD. The MOS 36-itern short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
17. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-555.
18. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4:502-506.
19. Mannino DM, Doherty DE, Buist SA. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006;100: 115-122.
20. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ 2002; 51:1-16.
21. Chang SC, Chang HI, Chen FJ, Shiao GM, Wang SS, Lee SD. Therapeutic effects of diuretics and paracentesis on-lung function in patients with non-alcoholic cirrhosis and tense ascites. J Hepatol 1997;26:833-838.
22. Chao Y, Wang SS, Lee SD, Shiao GM, Chang HI, Chang SC. Effect of large-volume paracentesis on pulmonary function in patients with cirrhosis and tense ascites. J Hepatol 1994;20:101-105.
23. Ehlers SL, Rodrigue JR, Widows MR, Reed AI, Nelson DR. Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research. Liver Transpl 2004;10:412-417.
24. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001; 7:S109-S118.
25. Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 2005;80:759-764.
26. Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001;96:2199-2205.